Bloom Energy (formerly, Ion America) is an American company that innovates and creates SOFCs (Solid oxide fuel cells) which utilize a unique chemical conversion process, The electricity is then used to power data centers, commercial products, manufacturing and etc. Due to the key role this company holds in not only AI research but in multiple other sectors, it is prime to have major growth. Current Financials show an increase in annual revenue of +37.3% or 550.1 million dollar increase from last years revenue. Along with many government incentives to increase cleaner energy sources. The New York Times even stating SOFCs are "considered the most efficient but most technologically challenging fuel-cell technology.”, Which shows that this company has high potential for growth, and from the current trajectory with recent deals including a 1 GW supply agreement with American Electric Power, $5 Billion Brook field Partnership, and a $2.65 Billion AEP Deal. The future of the company is one of success.

Viking Therapeutics is in development of its product known as “VK2809” which is a drug that helps with weight loss, currently in late-stage development and soon to release. How the drug works is by activating certain receptors in the liver that increase metabolism to burn through more fat. Once the drug really is on the market its safe to assume that large pharmaceutical companies will want an acquisition of the company which will benefit stock performance. Another argument to make is current sentiment is driving stock prices down, due to below expected test results analyst have mix sentiments on the company, thus putting the stock on a discount for buyers. The company at the moment has a negative free cash flow at approximately -278,685,000$ on the off chance the company isn’t able to produce a revenue source its would be of use to assume the company will file for bankruptcy. This stock in particular is one of volatility due to factors that have not been properly determined and could be a considered a potential “gamble”. This stock is best suited for investors with a lower, more flexible risk management.

Klaviyo (KVYO) is a marketing tool similar to how Salesforce operates, using AI integration the company can Unify customer data, Enables messaging and SMS messaging, Marketing automation (Streamlining communication), AI powered personalization and etc. Unlike Salesforce this company is a small to middle size company with a market cap of 5 billion dollars, for an investor who has a stricter risk management, mid-capped companies offer a good balance between the growth of a small cap stock, and stability of a large cap stock. Along with this, the company has had a year-over-year growth of 32%, outperforming Salesforce by above 3x. With current market sentiment showing bullish behavior, future investors can ride this trend.

This content is for informational and educational purposes only and should not be considered financial, investment, or legal advice. I am not a licensed financial advisor.